Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 11 pages · English
ECS Botanics Holdings Ltd (ASX: ECS) (“ECS” or the “Company”), a leading medicinal cannabis company, provides the following update on activities and cash flow for the quarter ended 31 December 2025 (Q2 FY26). Highlights: • Positive Operating Cash Flow: Achieved $218k in operating cash, a $1.5m turnaround on the prior year’s December quarter. • B2C Momentum: Branded B2C portfolio contributed 65% of
Ecs Botanics Holdings Ltd on 6ix
Story so far
Earlier from Ecs Botanics
- ECS Botanics advances preparations for US market entry
- ECS launches Woman Health Brand
- ECS Launches Sugar-Free Gummies as B2C Sales Surpass 60%
- ECS successfully completes $1.95m placement
- Trading Halt
Later from Ecs Botanics
- Security Class Suspension from Quotation - ECSO
- Security Class Reinstatement to Quotation - ECSO
- ECS Enters German Distribution Partnership with OzSun
- Half Yearly Report and Accounts
- H1 FY26 Results-Return to Profitability & Positive Cashflow
Follow Ecs Botanics into a list and get an email when it puts out news.
Follow Ecs Botanics